樂惠國際(603076.SH):孫公司擬與自然人金鑫設合資公司 建年產能5000噸的鮮啤30公里瀋陽城市工廠
格隆匯3月24日丨樂惠國際(603076.SH)公佈,公司第三屆董事會第四次會議決議,審議通過了《關於投資設立鮮啤30公里瀋陽合資公司的議案》。
公司孫公司寧波三十公里投資有限公司與自然人金鑫共同出資設立瀋陽鮮啤三十公里科技有限公司(暫定名,最終以市場監督管理局核准登記為準)(“合資公司”),建設年產能5000噸的鮮啤30公里瀋陽城市工廠。
合資公司註冊資本3000萬元,其中寧波三十公里投資有限公司以貨幣方式認繳出資1530萬元,佔合資公司註冊資本51%;金鑫以貨幣方式認繳出資1470萬元,佔合資公司註冊資本49%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.